Search for Clinical Trial Results
Papillary Renal Cell Carcinoma - 26 Studies Found
Status | Study |
Active, not recruiting |
Study Name: Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer Condition:
|
Active, not recruiting |
Study Name: Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer Condition:
|
Recruiting |
Study Name: A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Advanced or Metastatic Renal Cell Carcinoma Condition:
|
Completed |
Study Name: Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer Condition:
|
Completed |
Study Name: Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors Condition:
|
RECRUITING |
Study Name: Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer, PAPMET2 Trial Condition: Metastatic Papillary Renal Cell Carcinoma Date: 2024-05-18 Interventions: Given IV |